Effect of long-term mesoglycan treatment on fibrinogen plasma levels in patients with ischemic cerebrovascular disease

Autor:	V. Vecchione, V. Provitera, E. Troisi, Giuseppe Orefice, Rubino S, Pietro Biagio Carrieri, M. Selvaggio
Rok vydání:	1992
Předmět:	Pharmacology medicine.medical_specialty business.industry Antithrombin Ischemia Fibrinogen medicine.disease Gastroenterology Endocrinology Coagulative necrosis Mesoglycan Oral administration Internal medicine Blood plasma Toxicity medicine Pharmacology (medical) business medicine.drug
Zdroj:	Current Therapeutic Research. 52:666-670
ISSN:	0011-393X
DOI:	10.1016/s0011-393x(05)80508-9
Popis:	Thirty patients who had previously had an atherothrombotic stroke received mesoglycan 50 mg BID for 3 months to evaluate the effect of the drug on plasma fibrinogen levels, antithrombin III concentration, and other coagulative parameters. After 7 days of treatment, mesoglycan significantly decreased plasma fibrinogen levels ( P P P
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::69bedd3ff578ecc2ce6a593d77aa9e98 https://doi.org/10.1016/s0011-393x(05)80508-9 Zobrazit plný text záznamu